Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -111.88x is 59% above its 5-year average of -269.85x, near the high end of its 5-year range (-10339.00x–-4.09x).
0.18% below its 12-month average of -111.68x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -109.68x.
INTEREST COVERAGE RATIO
-111.88x
INTEREST COVERAGE RATIO AVG TTM
-111.68x
INTEREST COVERAGE RATIO AVG 3Y
-262.03x
INTEREST COVERAGE RATIO AVG 5Y
-269.85x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.18%
CURRENT VS 3Y AVG
+57.30%
CURRENT VS 5Y AVG
+58.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1654.98%
vs the sector median at left
Bionano Genomics, Inc.
Market Cap
$16.64M
Interest Coverage Ratio
-111.88x
TTM Avg
-111.68x
3Y Avg
-262.03x
5Y Avg
-269.85x
Market Cap
$16.74M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$16.52M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$16.82M
Interest Coverage Ratio
-49.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.84M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$17.31M
Interest Coverage Ratio
N/A
TTM Avg
15.47x
3Y Avg
15.47x
5Y Avg
15.47x
Market Cap
$17.39M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.64M | -111.88x | -111.68x | -262.03x | -269.85x |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -15.67x | 0.81x | 0.81x | 0.81x |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -49.05x | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | N/A | 1.00x | 1.00x | 1.00x |
| PAVmed Inc. (PAVM)vs › | $17.07M | -1038.38x | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.31M | N/A | 15.47x | 15.47x | 15.47x |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -6.31x | 0.97x | 0.97x | 0.97x |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -68.14x | N/A | N/A | N/A |
Interest Coverage
-111.9x
Debt/Equity
0.21
Current Ratio
2.48
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -109.68x |
| 2025-12-31 | -118.56x |
| 2025-09-30 | -123.74x |
| 2025-06-30 | -106.85x |
| 2025-03-31 | -99.59x |
| 2024-12-31 | -442.26x |
| 2024-09-30 | -645.60x |
| 2024-06-30 | -229.97x |
| 2024-03-31 | -255.11x |
| 2023-12-31 | -4.09x |
| 2023-09-30 | -1594.54x |
| 2023-06-30 | -510.93x |
| 2023-03-31 | -497.93x |
| 2022-12-31 | -500.36x |
| 2022-09-30 | -440.40x |
| 2022-06-30 | -433.50x |
| 2022-03-31 | -388.87x |
| 2021-12-31 | -139.72x |
| 2021-09-30 | -10339.00x |
| 2021-06-30 | -61.48x |
| 2021-03-31 | -18.51x |
| 2020-12-31 | -18.30x |
| 2020-09-30 | -17.36x |
| 2020-06-30 | -13.25x |
| 2020-03-31 | -12.83x |
| 2019-12-31 | -8.23x |
| 2019-09-30 | -9.84x |
| 2019-06-30 | -10.61x |
| 2019-03-31 | -22.70x |
| 2018-12-31 | -22.84x |
| 2018-09-30 | -14.76x |
| 2018-06-30 | -9.84x |
| 2018-03-31 | -14.36x |
| 2017-12-31 | -32.84x |
| 2017-09-30 | -34.62x |
| 2017-06-30 | -47.01x |
| 2017-03-31 | -43.49x |
